PL3021858T3 - Szczep cu1 do leczenia i/lub profilaktyki przewlekłych zapalnych chorób reumatycznych - Google Patents

Szczep cu1 do leczenia i/lub profilaktyki przewlekłych zapalnych chorób reumatycznych

Info

Publication number
PL3021858T3
PL3021858T3 PL14738881T PL14738881T PL3021858T3 PL 3021858 T3 PL3021858 T3 PL 3021858T3 PL 14738881 T PL14738881 T PL 14738881T PL 14738881 T PL14738881 T PL 14738881T PL 3021858 T3 PL3021858 T3 PL 3021858T3
Authority
PL
Poland
Prior art keywords
strain
prevention
treatment
chronic inflammatory
inflammatory rheumatism
Prior art date
Application number
PL14738881T
Other languages
English (en)
Inventor
Patrick Taillade
Marie URDACI
Original Assignee
Lesaffre Et Compagnie
École Nationale Supérieure Des Sciences Agronomiques De Bordeaux-Aquitaine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre Et Compagnie, École Nationale Supérieure Des Sciences Agronomiques De Bordeaux-Aquitaine filed Critical Lesaffre Et Compagnie
Publication of PL3021858T3 publication Critical patent/PL3021858T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL14738881T 2013-06-28 2014-06-24 Szczep cu1 do leczenia i/lub profilaktyki przewlekłych zapalnych chorób reumatycznych PL3021858T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1356274A FR3007655B1 (fr) 2013-06-28 2013-06-28 Souche bacillus subtilis pour le traitement et/ou la prevention de maladies inflammatoires chroniques
EP14738881.3A EP3021858B1 (fr) 2013-06-28 2014-06-24 Souche cu1 pour traitement et/ou prevention d'un rhumatisme inflammatoire chronique
PCT/FR2014/051561 WO2014207360A1 (fr) 2013-06-28 2014-06-24 Souche pour traitement et/ou prevention de maladies inflammatoires chroniques

Publications (1)

Publication Number Publication Date
PL3021858T3 true PL3021858T3 (pl) 2021-11-02

Family

ID=49151184

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14738881T PL3021858T3 (pl) 2013-06-28 2014-06-24 Szczep cu1 do leczenia i/lub profilaktyki przewlekłych zapalnych chorób reumatycznych

Country Status (11)

Country Link
US (1) US9750774B2 (pl)
EP (1) EP3021858B1 (pl)
JP (1) JP6533220B2 (pl)
CN (1) CN105358164B (pl)
AU (1) AU2014300853B2 (pl)
DK (1) DK3021858T3 (pl)
ES (1) ES2878674T3 (pl)
FR (1) FR3007655B1 (pl)
PL (1) PL3021858T3 (pl)
RS (1) RS62090B1 (pl)
WO (1) WO2014207360A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109415682B (zh) * 2016-06-27 2022-03-25 科丝美诗株式会社 新型鱼孢菌科微生物及其用途
TWI676682B (zh) * 2018-08-31 2019-11-11 財團法人食品工業發展研究所 枯草芽孢桿菌分離株及其用途
FR3153743A1 (fr) 2023-10-05 2025-04-11 Lesaffre Et Compagnie Effet bénéfique d’une bactérie probiotique Bacillus subtilis sur l’inflammation de bas grade
FR3167649A1 (fr) * 2024-10-21 2026-04-24 Lesaffre Et Compagnie Ascospores de levure Saccharomyces cerevisiae, sous forme sèche ou en suspension, leurs procédés de préparation et leurs utilisations
CN119823921A (zh) * 2025-03-18 2025-04-15 天津市英创技术有限公司 一株猫源枯草芽孢杆菌及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
DE69914932T2 (de) 1998-10-20 2004-12-09 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis
FR2837835B1 (fr) * 2002-03-29 2007-06-22 Maria Urdaci Souche bacillus subtilis cu1, son utilisation comme agent immunomodulateur du systeme immunitaire et vaccin recombinant vivant contre h. pylori la contenant
CA2535951A1 (en) 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20060177424A1 (en) * 2003-08-29 2006-08-10 Cobb Mark L Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
US8192733B2 (en) * 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20080057047A1 (en) 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
WO2007133188A1 (en) * 2006-05-01 2007-11-22 Cobb & Company, Llp Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
CN102387808A (zh) * 2009-02-20 2012-03-21 有限公司名将 免疫增强组成物及其制造方法
EP2547348B1 (en) * 2010-03-17 2015-05-20 Bayer Cropscience LP Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
FR2999191B1 (fr) * 2012-12-12 2016-02-05 Lesaffre & Cie Souches probiotiques pour le traitement et/ou la prevention de la diarrhee

Also Published As

Publication number Publication date
EP3021858B1 (fr) 2021-05-05
US9750774B2 (en) 2017-09-05
FR3007655A1 (fr) 2015-01-02
DK3021858T3 (da) 2021-07-12
AU2014300853A1 (en) 2015-12-24
JP2016523540A (ja) 2016-08-12
RS62090B1 (sr) 2021-08-31
WO2014207360A1 (fr) 2014-12-31
CN105358164A (zh) 2016-02-24
AU2014300853B2 (en) 2019-05-16
CN105358164B (zh) 2020-01-03
EP3021858A1 (fr) 2016-05-25
FR3007655B1 (fr) 2016-12-23
ES2878674T3 (es) 2021-11-19
US20160136209A1 (en) 2016-05-19
JP6533220B2 (ja) 2019-06-19

Similar Documents

Publication Publication Date Title
IL273688A (en) Evaluation and treatment of bradykinin-mediated disorders
EP2983657A4 (en) TREATMENT OF GASTROINTESTINAL AND OTHER DISEASES
SG11201506052PA (en) Combination of vaccination and inhibition of the pd-1 pathway
EP3068289A4 (en) Prevention and treatment of bed exits, falls, and other conditions
EP2968318A4 (en) ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES
IL262302B (en) Beta-casein a2 and prevention of intestinal inflammation
IL244317B (en) Cortistatin analogs for the treatment of inflammatory and/or immune diseases
ZA201507724B (en) The treatment of inflammatory disorders
PL3021858T3 (pl) Szczep cu1 do leczenia i/lub profilaktyki przewlekłych zapalnych chorób reumatycznych
SI3197556T1 (sl) Sestavek za preprečevanje in/ali zdravljenje alergijskih simptomov
IL252779B (en) Prevention and treatment of inflammatory diseases
TWI559919B (en) The uses of hydroxyl polymethoxylflavones and/or derivative thereof
SG2013079843A (en) Use of tocotrienols in the treatment or prevention of ulcerative colitis
SG11201505909WA (en) Treatment and prevention of acne
GB201309431D0 (en) Treatment and prevention of malaria
PL2857023T3 (pl) Zastosowanie odiparcilu w leczeniu mukopolisacharydozy
GB201317373D0 (en) Treatment and prevention of cancer
GB201416605D0 (en) Combination therapy to reduce the risk of and to treat cancer